Navigating the complex landscape of non-dilutive funding can be daunting for many innovators and researchers. Identifying suitable grants that align…
AndyJune 17, 2024
ROCKVILLE, Md. and SUZHOU, China, June 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855 HK), a global biopharmaceutical company engaged in developing novel therapies for…
AndyJune 17, 2024
Join us for an enlightening episode of BioTalk with Rich Bendis as we welcome Dan Berglund, President and CEO of…
AndyJune 17, 2024
Join us for an enlightening episode of BioTalk with Rich Bendis as we welcome Dan Berglund, President and CEO of…
AndyJune 17, 2024
GERMANTOWN, MD / ACCESSWIRE / June 14, 2024 / Seraxis, Inc., a regenerative medicine company developing pancreatic islet replacement therapies to…
AndyJune 16, 2024
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
GAITHERSBURG, Md., June 14, 2024/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that…
AndyJune 16, 2024
WASHINGTON, June 13, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it has received a revised…
AndyJune 14, 2024
COLUMBIA, Md., (June 13, 2024) — The Maryland Innovation Initiative (MII) Board of Directors announces the appointment of Abishek Kulshreshtha…
AndyJune 13, 2024
CHARLOTTESVILLE, VA / ACCESSWIRE / June 11, 2024 / KeViRx, Inc., an innovative, early-stage pharmaceutical company, announced today the receipt of $1.99 million…
AndyJune 12, 2024